2024 Q2 Form 10-K Financial Statement
#000149315224014897 Filed on April 17, 2024
Income Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $196.1K | $3.412M | $15.11M |
YoY Change | -95.91% | 3468.66% | 467.49% |
Cost Of Revenue | $20.10K | $3.750M | $14.02M |
YoY Change | -99.53% | 5014.18% | 841.78% |
Gross Profit | $176.0K | -$337.4K | $1.090M |
YoY Change | -65.73% | -1612.87% | -7.15% |
Gross Profit Margin | 89.75% | -9.89% | 7.21% |
Selling, General & Admin | $1.084M | $1.068M | $3.519M |
YoY Change | 24.78% | 147.34% | 64.93% |
% of Gross Profit | 616.08% | 322.8% | |
Research & Development | $0.00 | ||
YoY Change | |||
% of Gross Profit | 0.0% | ||
Depreciation & Amortization | $2.969K | $14.59K | $32.85K |
YoY Change | -8.76% | 94.02% | 9.22% |
% of Gross Profit | 1.69% | 3.01% | |
Operating Expenses | $1.150M | $1.036M | $3.746M |
YoY Change | 29.16% | 135.8% | 73.09% |
Operating Profit | -$973.9K | -$1.373M | -$2.655M |
YoY Change | 158.59% | 229.33% | 168.29% |
Interest Expense | -$127.7K | -$430.0K | -$1.811M |
YoY Change | -75.07% | -38.26% | 24.31% |
% of Operating Profit | |||
Other Income/Expense, Net | $142.0K | $40.00 | $81.58K |
YoY Change | -137.43% | -99.86% | -93.05% |
Pretax Income | -$831.9K | -$3.058M | -$5.510M |
YoY Change | 10.03% | -308.0% | -3425.48% |
Income Tax | $13.20K | $22.17K | |
% Of Pretax Income | |||
Net Earnings | -$831.9K | -$3.107M | -$5.660M |
YoY Change | 9.8% | -308.61% | -3939.83% |
Net Earnings / Revenue | -424.15% | -91.05% | -37.45% |
Basic Earnings Per Share | -$0.02 | $0.14 | |
Diluted Earnings Per Share | -$0.02 | -$0.08 | -$0.15 |
COMMON SHARES | |||
Basic Shares Outstanding | 42.50M shares | 38.97M shares | 38.45M shares |
Diluted Shares Outstanding | 43.09M shares | 38.45M shares |
Balance Sheet
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.351M | $1.223M | $1.223M |
YoY Change | -15.43% | 719.47% | 719.47% |
Cash & Equivalents | $387.9K | $174.9K | |
Short-Term Investments | $962.6K | $1.048M | $1.048M |
Other Short-Term Assets | $545.8K | $1.841M | $1.841M |
YoY Change | -77.38% | -0.8% | -0.8% |
Inventory | $719.3K | $974.9K | $974.9K |
Prepaid Expenses | |||
Receivables | $1.946M | $1.759M | $1.759M |
Other Receivables | $103.3K | $952.9K | $952.9K |
Total Short-Term Assets | $4.837M | $6.751M | $6.751M |
YoY Change | -31.33% | 69.19% | 69.19% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $3.676K | $532.7K | $532.7K |
YoY Change | -92.11% | 3495.17% | 209.36% |
Goodwill | $748.0K | $748.0K | |
YoY Change | 0.0% | 0.0% | |
Intangibles | |||
YoY Change | |||
Long-Term Investments | $547.4K | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Other Assets | $112.2K | $67.13K | $67.13K |
YoY Change | 231.87% | 117.31% | 117.32% |
Total Long-Term Assets | $4.476M | $4.178M | $4.178M |
YoY Change | 19.24% | 1.3% | 1.3% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.837M | $6.751M | $6.751M |
Total Long-Term Assets | $4.476M | $4.178M | $4.178M |
Total Assets | $9.313M | $10.93M | $10.93M |
YoY Change | -13.75% | 34.68% | 34.68% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $954.3K | $964.1K | $964.1K |
YoY Change | 66.41% | 12.04% | 12.04% |
Accrued Expenses | $529.7K | $933.2K | $933.2K |
YoY Change | 336.84% | 683.99% | 205.49% |
Deferred Revenue | $41.46K | $210.3K | |
YoY Change | -93.06% | 161.34% | |
Short-Term Debt | $2.695M | $2.561M | $2.561M |
YoY Change | -18.49% | 117.68% | 117.68% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.537M | $4.802M | $4.802M |
YoY Change | -7.79% | -23.0% | -23.0% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $196.1K | $257.9K | $257.9K |
YoY Change | 38.01% | ||
Total Long-Term Liabilities | $196.1K | $257.9K | $257.9K |
YoY Change | 38.01% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.537M | $4.802M | $4.802M |
Total Long-Term Liabilities | $196.1K | $257.9K | $257.9K |
Total Liabilities | $4.733M | $5.817M | $5.817M |
YoY Change | -6.5% | -6.73% | -6.73% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$25.43M | -$22.98M | |
YoY Change | 33.08% | 33.04% | |
Common Stock | $44.58K | $39.15K | |
YoY Change | 15.02% | 5.32% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $4.580M | $5.112M | $5.112M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $9.313M | $10.93M | $10.93M |
YoY Change | -13.75% | 34.68% | 34.68% |
Cashflow Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$831.9K | -$3.107M | -$5.660M |
YoY Change | 9.8% | -308.61% | -3939.83% |
Depreciation, Depletion And Amortization | $2.969K | $14.59K | $32.85K |
YoY Change | -8.76% | 94.02% | 9.22% |
Cash From Operating Activities | -$740.4K | -$940.9K | -$4.783M |
YoY Change | -62.6% | 199.2% | 113.14% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $45.45K | $80.83K |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$300.00 | -$287.3K | -$237.8K |
YoY Change | -102.88% | 493.66% | -83.46% |
Cash From Investing Activities | -$300.00 | -$332.7K | -$318.6K |
YoY Change | -98.82% | 587.56% | -77.83% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $4.082M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 840.5K | 1.190M | 5.096M |
YoY Change | -1052.74% | 368.7% | 82.09% |
NET CHANGE | |||
Cash From Operating Activities | -740.4K | -940.9K | -4.783M |
Cash From Investing Activities | -300.0 | -332.7K | -318.6K |
Cash From Financing Activities | 840.5K | 1.190M | 5.096M |
Net Change In Cash | 99.82K | -83.58K | -5.200K |
YoY Change | -104.77% | -23.29% | -99.5% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$740.4K | -$940.9K | -$4.783M |
Capital Expenditures | $0.00 | $45.45K | $80.83K |
Free Cash Flow | -$740.4K | -$986.3K | -$4.864M |
YoY Change | -63.27% | 116.74% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001329606 | |
CY2023Q4 | CETY |
Lease Receivable Asset Current
LeaseReceivableAssetCurrent
|
usd | |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
usd | |
CY2022Q4 | CETY |
Intangible Assets Net
IntangibleAssetsNet
|
usd | |
CY2023Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
usd | |
CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
usd | |
CY2022Q4 | CETY |
Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
usd | |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
usd | |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
usd | |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
usd | |
CY2023 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
usd | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | |
CY2023 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
usd | |
CY2023 | CETY |
Financing Fees
FinancingFees
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
usd | |
CY2023 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | |
CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | |
CY2022 | CETY |
Payments From Loans Receivable
PaymentsFromLoansReceivable
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2022 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
usd | |
CY2022 | us-gaap |
Stock Issued1
StockIssued1
|
usd | |
CY2022 | CETY |
Warrants Issued In Conjunction For Convertible Notes Payable
WarrantsIssuedInConjunctionForConvertibleNotesPayable
|
usd | |
CY2023 | CETY |
Forgiveness Debt
ForgivenessDebt
|
usd | |
CY2022Q4 | CETY |
Accounts Receivable Rp
AccountsReceivableRp
|
usd | |
CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
usd | |
CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
usd | |
CY2022Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrincic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrincicValue
|
usd | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
|
shares | |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceExpired
|
||
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueExpired
|
usd | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueAddition
|
usd | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueAdditions
|
usd | |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrincic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrincicValue
|
usd | |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
20721204 | usd |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
42495453 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5854 | |
CY2023 | dei |
Auditor Name
AuditorName
|
TAAD, LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Diamond Bar, California | |
CY2023Q4 | us-gaap |
Cash
Cash
|
174851 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
149272 | usd |
CY2022Q4 | CETY |
Lease Receivable Asset Current
LeaseReceivableAssetCurrent
|
217584 | usd |
CY2023Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
11000 | usd |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
204556 | usd |
CY2023Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
752066 | usd |
CY2023Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
200826 | usd |
CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
116000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
974894 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
500586 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
6750728 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3990136 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
78688 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
14816 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
747976 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
747976 | usd |
CY2023Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
1468709 | usd |
CY2022Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
1468709 | usd |
CY2023Q4 | CETY |
Intangible Assets Net
IntangibleAssetsNet
|
12914 | usd |
CY2022Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
561656 | usd |
CY2023Q4 | us-gaap |
Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
|
902354 | usd |
CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
|
684770 | usd |
CY2023Q4 | CETY |
License Noncurrent
LicenseNoncurrent
|
354322 | usd |
CY2022Q4 | CETY |
License Noncurrent
LicenseNoncurrent
|
354322 | usd |
CY2023Q4 | CETY |
Patents
Patents
|
91817 | usd |
CY2022Q4 | CETY |
Patents
Patents
|
103693 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
453970 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
157359 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
67133 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
30892 | usd |
CY2023Q4 | us-gaap |
Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
|
4177883 | usd |
CY2022Q4 | us-gaap |
Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
|
4109377 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
10928611 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
8114329 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
586372 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
119030 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
210310 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
80475 | usd |
CY2023Q4 | CETY |
Warranty Liability Current
WarrantyLiabilityCurrent
|
100000 | usd |
CY2022Q4 | CETY |
Warranty Liability Current
WarrantyLiabilityCurrent
|
100000 | usd |
CY2023Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
33000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
33000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
588178 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
346807 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
186436 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
626033 | usd |
CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
998820 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
70056 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
326805 | usd |
CY2023Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1934956 | usd |
CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
3092055 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4801523 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6236132 | usd |
CY2023Q4 | CETY |
Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
|
209986 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
257890 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
5059413 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
6236132 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
CY2023Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
47904 | usd |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39152455 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
39152455 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
37174879 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
37174879 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
39152 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
37175 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
28251621 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19278230 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-196827 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-160673 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22984163 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17276536 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5111982 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1878196 | usd |
CY2023Q4 | us-gaap |
Minority Interest
MinorityInterest
|
757216 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5869198 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1878196 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10928611 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8114328 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15113463 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2663212 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
684893 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
400322 | usd |
CY2023 | us-gaap |
Salaries And Wages
SalariesAndWages
|
1671071 | usd |
CY2022 | us-gaap |
Salaries And Wages
SalariesAndWages
|
782657 | usd |
CY2023 | CETY |
Facility Lease And Maintenance
FacilityLeaseAndMaintenance
|
401293 | usd |
CY2022 | CETY |
Facility Lease And Maintenance
FacilityLeaseAndMaintenance
|
349610 | usd |
CY2023 | CETY |
Consulting
Consulting
|
199594 | usd |
CY2022 | CETY |
Consulting
Consulting
|
119896 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
26692 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
30076 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
3745662 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
2163947 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2655408 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-989751 | usd |
CY2023 | us-gaap |
Other Income
OtherIncome
|
81583 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
55403 | usd |
CY2023 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
326539 | usd |
CY2022 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-331495 | usd |
CY2023 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-1124654 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
2556916 | usd |
CY2023 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
2137649 | usd |
CY2022 | us-gaap |
Financing Interest Expense
FinancingInterestExpense
|
1125395 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5509589 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
165678 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22173 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
18283 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-5531762 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
147395 | usd |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
127961 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5659723 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
147395 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-36155 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-160673 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5695878 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13278 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
38447916 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
38447916 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27681722 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27681722 | shares |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.14 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.14 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1721712 | usd |
CY2022 | CETY |
Stock Issued During Period Value For Warrant Conversion
StockIssuedDuringPeriodValueForWarrantConversion
|
471278 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1202800 | usd |
CY2022 | CETY |
Stock Issued During Period Value For Note Conversion
StockIssuedDuringPeriodValueForNoteConversion
|
1548904 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
0 | usd |
CY2022 | CETY |
Stock Issued During Period Value Issued For S1
StockIssuedDuringPeriodValueIssuedForS1
|
291145 | usd |
CY2022 | CETY |
Stock Issued During Period Value Contribution To Capital
StockIssuedDuringPeriodValueContributionToCapital
|
80000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-160673 | usd |
CY2022 | CETY |
Net Loss
NetLoss
|
166454 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1878196 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1878196 | usd |
CY2023 | CETY |
Adjustments To Additional Paid In Capital Warrants Issued In Conjunction For Debt
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionForDebt
|
609619 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
76100 | usd |
CY2023 | CETY |
Stock Issued During Period Value Issued For S1
StockIssuedDuringPeriodValueIssuedForS1
|
3900000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
805445 | usd |
CY2023 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
64225 | shares |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
-4 | usd |
CY2023 | CETY |
Stock Issued During Period Value Issued For Debt Conversion
StockIssuedDuringPeriodValueIssuedForDebtConversion
|
666250 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-57850 | usd |
CY2023 | CETY |
Fair Value Of Nci From Acquisition
FairValueOfNciFromAcquisition
|
650951 | usd |
CY2023 | CETY |
Stock Issued During Period Value For Warrant Conversion
StockIssuedDuringPeriodValueForWarrantConversion
|
987203 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
261639 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
72000 | usd |
CY2023 | CETY |
Stock Issued During Period Value For Series E Preferred
StockIssuedDuringPeriodValueForSeriesEPreferred
|
3210206 | usd |
CY2023 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
47904 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-5531762 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5869198 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5869198 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5659723 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
147395 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
32850 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
30076 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
148100 | usd |
CY2023 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-1124654 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
2556916 | usd |
CY2023 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
846682 | usd |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
350470 | usd |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-5467 | usd |
CY2022 | CETY |
Financing Fees
FinancingFees
|
416014 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
204556 | usd |
CY2023 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-326539 | usd |
CY2022 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
331495 | usd |
CY2023 | CETY |
Increase Decrease In Right Of Use Asset1
IncreaseDecreaseInRightOfUseAsset1
|
-297201 | usd |
CY2022 | CETY |
Increase Decrease In Right Of Use Asset1
IncreaseDecreaseInRightOfUseAsset1
|
238248 | usd |
CY2023 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
371240 | usd |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-234816 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
81756 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-183368 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
38394 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-561597 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
312460 | usd |
CY2023 | CETY |
Decrease Increase In Accrued Interest
DecreaseIncreaseInAccruedInterest
|
26771 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
435417 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
557436 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-543036 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
4091 | usd |
CY2022 | CETY |
Decrease Increase In Accrued Interest
DecreaseIncreaseInAccruedInterest
|
155162 | usd |
CY2023 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
127350 | usd |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
56435 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4783077 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2244133 | usd |
CY2022 | us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
116000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-318602 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1437123 | usd |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
68207 | usd |
CY2023 | CETY |
Proceeds From Notes Payable And Lines Of Credit
ProceedsFromNotesPayableAndLinesOfCredit
|
2605539 | usd |
CY2022 | CETY |
Proceeds From Notes Payable And Lines Of Credit
ProceedsFromNotesPayableAndLinesOfCredit
|
2180460 | usd |
CY2023 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
987204 | usd |
CY2023 | CETY |
Payments From Loans Receivable
PaymentsFromLoansReceivable
|
-84720 | usd |
CY2023 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1675535 | usd |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
807312 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3094555 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1493945 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5096483 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2798885 | usd |
CY2023 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
30776 | usd |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-160673 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
25580 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1043043 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
149272 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1192315 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
174851 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
149272 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
257149 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
671510 | usd |
CY2023 | CETY |
Discount On Derivatives
DiscountOnDerivatives
|
239800 | usd |
CY2022 | CETY |
Discount On Derivatives
DiscountOnDerivatives
|
471278 | usd |
CY2023 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
261639 | usd |
CY2023 | us-gaap |
Stock Issued1
StockIssued1
|
3210206 | usd |
CY2023 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
666250 | usd |
CY2022 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1548904 | usd |
CY2023 | CETY |
Warrants Issued In Conjunction For Convertible Notes Payable
WarrantsIssuedInConjunctionForConvertibleNotesPayable
|
609619 | usd |
CY2022 | CETY |
Forgiveness Debt
ForgivenessDebt
|
80000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
5869198 | usd |
CY2023Q4 | CETY |
Working Capital Deficit
WorkingCapitalDeficit
|
-1949206 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22984163 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4783077 | usd |
CY2023 | us-gaap |
Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
|
8000000 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84E_eus-gaap--UseOfEstimates_ztuNwCiI6DW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zylPLYVPZLgd">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
95000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
95000 | usd |
CY2023Q4 | us-gaap |
Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
|
247500 | usd |
CY2022Q4 | us-gaap |
Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
|
247500 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
934344 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
897808 | usd |
CY2023 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2023 | CETY |
Final Payment Percentage
FinalPaymentPercentage
|
0.10 | pure |
CY2023Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
33000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
33000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
210310 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
80475 | usd |
CY2023Q1 | CETY |
Business Combination Contingent Non Controlling Interest Percentage
BusinessCombinationContingentNonControllingInterestPercentage
|
0.51 | pure |
CY2023Q1 | us-gaap |
Derivative Net Assets Percentage
DerivativeNetAssetsPercentage
|
1 | pure |
CY2023 | CETY |
Weighted Average Number Shares Outstanding Adjustment
WeightedAverageNumberSharesOutstandingAdjustment
|
39152455 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
38447916 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
27681722 | shares |
CY2023 | CETY |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
38227965 | shares |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
0 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
0 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
15113463 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2663212 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1090254 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1174196 | usd |
CY2023Q4 | CETY |
Selected Financial Assets
SelectedFinancialAssets
|
11511037 | usd |
CY2022Q4 | CETY |
Selected Financial Assets
SelectedFinancialAssets
|
8114329 | usd |
CY2023 | CETY |
Total Sales Selected Financial
TotalSalesSelectedFinancial
|
15113463 | usd |
CY2022 | CETY |
Total Sales Selected Financial
TotalSalesSelectedFinancial
|
2567596 | usd |
CY2023 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
0 | usd |
CY2022 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
0 | usd |
CY2023 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
On December 22, 2018 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the “Tax Act”) was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (“Federal Tax Rate”) from 35% to 21% effective January 1, 2018. The Company will compute its income tax expense for the year ended December 31, 2022 using a Federal Tax Rate of 21% and an estimated state of California rate of 9%. | |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
15737415 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
4727224 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
4727224 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1430337 | usd |
CY2023 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyLjKUmazAJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zyiYDpAkFHe7">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported income, total assets, or stockholders’ equity as previously reported.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
11000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
1362130 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
1388567 | usd |
CY2023Q4 | CETY |
Accounts Receivable Rp
AccountsReceivableRp
|
491774 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
95000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
95000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1758904 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1293567 | usd |
CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
1909238 | usd |
CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
1389394 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
934344 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
897808 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
974894 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
500586 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1509025 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1430260 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1415444 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
78688 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
14816 | usd |
CY2023 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
26692 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
30076 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
747976 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
747976 | usd |
CY2023Q4 | us-gaap |
Investments
Investments
|
1468709 | usd |
CY2022Q4 | us-gaap |
Investments
Investments
|
1468709 | usd |
CY2023Q4 | CETY |
License
License
|
354322 | usd |
CY2022Q4 | CETY |
License
License
|
354322 | usd |
CY2023Q4 | CETY |
Patents Gross
PatentsGross
|
190789 | usd |
CY2022Q4 | CETY |
Patents Gross
PatentsGross
|
190789 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
98972 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
87096 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2682893 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2674700 | usd |
CY2023 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11876 | usd |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11876 | usd |
CY2023 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
58273 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
104775 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
102370 | usd |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
433936 | usd |
CY2022Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
16660 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
586372 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
119030 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
626033 | usd |
CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
998820 | usd |
CY2022 | CETY |
Gain On Debt Payment
GainOnDebtPayment
|
2556916 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
1697757 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
3156528 | usd |
CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
308216 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
262331 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
71017 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
326804 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1934956 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3092055 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
588178 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Description
LesseeOperatingLeaseDescription
|
Effective August 5, 2022, Shuya entered a 48-month lease for a natural gas recycle station from Leishen (the 41% shareholder of Shuya), including the operating rights and use rights of all the assets and equipment in the station. The annual rent is approximately $64,290, to be paid each year in advance, however, it has not been paid since the lease commenced. Effective August 5, 2022, Shuya entered another 48-month lease for leasing sewage treatment land from Leishen to operate the natural gas recycling station. The annual rent is approximately $17,137, to be paid each year in advance, which has not been fully paid since the lease commenced. | |
CY2023 | us-gaap |
Lease Cost
LeaseCost
|
401293 | usd |
CY2022 | us-gaap |
Lease Cost
LeaseCost
|
349610 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
shares of Common Stock such that each (40) shares of Old Common Stock shall be reclassified as and combined into one (1) share of New Common Stock | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
375875 | shares |
CY2022Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
3.20 | |
CY2022Q1 | us-gaap |
Legal Fees
LegalFees
|
45498 | usd |
CY2022Q2 | us-gaap |
Legal Fees
LegalFees
|
34500 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
|
3745 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
2000000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
39152455 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Dividend And Interest Receivable
DividendAndInterestReceivable
|
47904 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
325243 | shares |
CY2022Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePrice
|
1.60 | |
CY2022 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeOutstanding
|
P3Y11M26D | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedAdditions
|
425438 | shares |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceAddition
|
1.60 | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeAddition
|
P4Y2M1D | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
26701 | shares |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceAdditions
|
5.00 | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeAdditions
|
P3Y10M24D | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
707280 | shares |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceExercised
|
1.60 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
70102 | shares |
CY2023Q4 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePrice
|
2.90 | |
CY2023 | CETY |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeOutstanding
|
P3Y8M15D | |
CY2023Q4 | CETY |
Warrant Liability
WarrantLiability
|
0 | usd |
CY2022Q4 | CETY |
Warrant Liability
WarrantLiability
|
0 | usd |
CY2023Q4 | CETY |
Principal Amount Outstanding On Warrant
PrincipalAmountOutstandingOnWarrant
|
100000 | usd |
CY2022Q4 | CETY |
Principal Amount Outstanding On Warrant
PrincipalAmountOutstandingOnWarrant
|
100000 | usd |
CY2022Q3 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
0 | usd |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
22173 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22173 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.068 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.001 | pure |
CY2023 | CETY |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Permanent Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRatePermanentDifferential
|
0.002 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.280 | pure |
CY2023 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.004 | pure |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
5686 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7021555 | usd |
CY2023Q4 | CETY |
Operating Lease Liabilities Net Of Right Of Use Assets
OperatingLeaseLiabilitiesNetOfRightOfUseAssets
|
2479 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7029720 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
7029720 | usd |
CY2023Q4 | CETY |
Net Operating Loss Carryforwards Federal Income Tax
NetOperatingLossCarryforwardsFederalIncomeTax
|
30080000.00 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
87148000000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7030000.00 | usd |
CY2023 | CETY |
Minimum Annual After Tax Profit
MinimumAnnualAfterTaxProfit
|
0.10 | pure |
CY2023 | CETY |
Surplus Reserve Percentage
SurplusReservePercentage
|
0.50 | pure |
CY2023 | CETY |
After Tax Profit Percentage
AfterTaxProfitPercentage
|
0.50 | pure |
CY2023 | CETY |
After Tax Income Percentage
AfterTaxIncomePercentage
|
0.10 | pure |
CY2023 | CETY |
Percentage Of Total Sales
PercentageOfTotalSales
|
0.15 | pure |